Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors

B. Markman, J. Tabernero, I. Krop, G. I. Shapiro, L. Siu, L. C. Chen, M. Mita, M. Melendez cuero, S. Stutvoet, D. Birle, Ö Anak, W. Hackl, J. Baselga

Research output: Contribution to journalArticleResearchpeer-review

102 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences